Review of therapeutic advances in diabetic retinopathy. - Wikidata - thesis-toulmin - TriplyDB

Review of therapeutic advances in diabetic retinopathy.

Review of therapeutic advances in diabetic retinopathy.

http://www.wikidata.org/entity/Q34475449

about

Elevated cell proliferation and VEGF production by high-glucose conditions in Müller cells involve XIAP.

P2860

Q37317179-86D3F57F-0E62-41B9-877D-2D0781CACCB0

P2860

Review of therapeutic advances in diabetic retinopathy.

http://www.wikidata.org/entity/Q34475449

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Review of therapeutic advances in diabetic retinopathy.

@ast

Review of therapeutic advances in diabetic retinopathy.

@en

Review of therapeutic advances in diabetic retinopathy.

@nl

type

label

Review of therapeutic advances in diabetic retinopathy.

@ast

Review of therapeutic advances in diabetic retinopathy.

@en

Review of therapeutic advances in diabetic retinopathy.

@nl

prefLabel

Review of therapeutic advances in diabetic retinopathy.

@ast

Review of therapeutic advances in diabetic retinopathy.

@en

Review of therapeutic advances in diabetic retinopathy.

@nl

P1433

Q34475449-E23F8D6E-2101-4AD2-A383-F66FBAA7B0F4

P1476

Q34475449-EAC4754C-32CF-4004-B1CE-45AABAD451E0

P2093

Q34475449-0B9B204C-4025-4B37-A5C6-9576780CA039

Q34475449-73610956-7BC8-4E94-A78F-F38E1615E220

P2860

Q34475449-065B9A95-CBDA-40CE-9E30-988434C8E644

Q34475449-0A2A6A27-7A9D-467C-A11B-162234FA9669

Q34475449-0D56DBE0-5BB3-49AD-8941-7E18E8A5D3F0

Q34475449-0F8B6DF5-8B5B-4E3F-BD62-F2F8EA0EEB8A

Q34475449-115111B5-67E7-49A8-A652-EC1D9578178E

Q34475449-13CFC13B-9E94-4606-B798-978A1BD97A93

Q34475449-1A336591-3BFA-4776-BD4F-25C6FA760FFF

Q34475449-1D261101-9133-47A9-B7D6-099161C55F89

Q34475449-1EDD8D1B-889E-40C3-B433-56846F545F21

Q34475449-2709DBAB-BCC6-40FA-839F-AA54DCC10C68

P304

Q34475449-42F37FEB-8A4E-4898-8AE0-94A47315DF92

P31

Q34475449-44A06CD8-CD2B-4CE5-91F7-E70E07FB8FC3

P356

Q34475449-0CEBAD8F-0851-4B74-B801-BFB894F1F1C5

P433

Q34475449-49B7FBF1-561B-452C-AAA3-5C2DA3064A57

P478

Q34475449-556BF183-3B5E-4ACE-85F8-A77974FA2CA3

P577

Q34475449-EC2C7006-D4F9-4CC9-8E45-BEEDDC6B59D8

P5875

Q34475449-2C76004A-559F-4CC8-9DD1-2F7262A0B141

P698

Q34475449-BC3DADF4-719E-4B75-8F7B-6E034EBAF05B

P932

Q34475449-EBA2A67E-7254-4A32-B8C0-391305DCAF91

P356

2042018810396750

P1433

Therapeutic advances in endocrinology and metabolism

P1476

Review of therapeutic advances in diabetic retinopathy.

@en

P2093

Carolyn Chen

http://www.w3.org/2001/XMLSchema#string

Chirag P Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Ranibizumab for neovascular age-related macular degeneration

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Vitrectomy in the management of diabetic retinopathy.

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.

Protein kinase C expression in the rabbit retina after laser photocoagulation.

VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.

P304

39-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042018810396750

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233405506

http://www.w3.org/2001/XMLSchema#string

P698

23148170

http://www.w3.org/2001/XMLSchema#string

P932

3474624

http://www.w3.org/2001/XMLSchema#string